Aurinia Pharmaceuticals Inc. (AUPH) Operating income 2018–2025
Aurinia Pharmaceuticals Inc. (AUPH) annual operating income history from SEC filings — each fiscal year as reported.
$104.9MFY2025 · since FY2018: -$55.2M → $104.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $104.9M | +2338.4% |
| FY2024 | -$4.7M | +94.9% |
| FY2023 | -$91.7M | +17.7% |
| FY2022 | -$111.5M | +38.3% |
| FY2021 | -$180.7M | -73.3% |
| FY2020 | -$104.3M | -14.7% |
| FY2019 | -$90.9M | -64.6% |
| FY2018 | -$55.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More AUPH financial trends
AUPH RevenueAUPH Net incomeAUPH Net marginAUPH Gross profitAUPH Gross marginAUPH Operating marginAUPH Operating cash flowAUPH Free cash flowAUPH Capital expendituresAUPH Return on equityAUPH Stock buybacksAUPH Dividends paidAUPH Total assetsAUPH Total liabilitiesAUPH Shareholders’ equityAUPH overview →